[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration

Acta Neuropathologica

Volumn 132, Issue 6, 2016, Pages 931-933

  Josephs, Keith A ^a   Whitwell, Jennifer L ^a   Tacik, Pawel ^b   Duffy, Joseph R ^a   Senjem, Matthew L ^a   Tosakulwong, Nirubol ^a   Jack, Clifford R ^a   Lowe, Val ^a   Dickson, Dennis W ^b   Murray, Melissa E ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLORTAUCIPIR F 18; TAU PROTEIN; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; 7-(6-FLUOROPYRIDIN-3-YL)-5H-PYRIDO(4,3-B)INDOLE; ANILINE DERIVATIVE; CARBOLINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; AUTOPSY; AUTORADIOGRAPHY; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CASE REPORT; CORTICOBASAL DEGENERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MIDDLE AGED; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; BASAL GANGLION; BRAIN CORTEX; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; METABOLISM;

ANILINE COMPOUNDS; AUTOPSY; BASAL GANGLIA; CARBOLINES; CEREBRAL CORTEX; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY; TAU PROTEINS; THIAZOLES;

EID: 84988416373     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-016-1618-1     Document Type: Letter

References (9)

1. Armstrong MJ, Litvan I, Lang AE et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503. doi:10.1212/WNL.0b013e31827f0fd1
2. Chien DT, Bahri S, Szardenings AK et al (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis 34:457–468. doi:10.3233/JAD-122059
3. Dickson DW, Bergeron C, Chin SS et al (2002) Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946
4. Josephs KA, Whitwell JL, Ahmed Z et al (2008) Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63:204–212. doi:10.1002/ana.21223
5. Josephs KA, Duffy JR, Strand EA et al (2012) Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 135:1522–1536. doi:10.1093/brain/aws032
6. Lowe VJ, Curran G, Fang P et al (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4:58. doi:10.1186/s40478-016-0315-6
7. Marquie M, Normandin MD, Vanderburg CR et al (2015) Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol 78:787–800. doi:10.1002/ana.24517
8. Sander K, Lashley T, Gami P et al (2016) Characterization of tau positron emission tomography tracer [F]AV-1451 binding to postmortem tissue in Alzheimer’s disease, primary tauopathies, and other dementias. Alzheimers Dement. doi:10.1016/j.jalz.2016.01.003
9. Smith R, Puschmann A, Scholl M et al (2016) 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain 139:2372–2379. doi:10.1093/brain/aww163